{
    "root": "bb517e6a-433f-08be-b011-12874eb9b6cd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Trelstar",
    "value": "20250314",
    "ingredients": [],
    "indications": {
        "text": "trelstar indicated treatment advanced prostate cancer [ ( 14 ) ] .",
        "doid_entities": [
            {
                "text": "prostate cancer (DOID:10283)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10283"
            },
            {
                "text": "cancer (DOID:162)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_162"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "trelstar administered single intramuscular injection either buttock . due different release characteristics , strengths additive must selected based upon desired dosing schedule . ( 2.1 ) 3.75 mg every 4 weeks . ( 2.1 ) 11.25 mg every 12 weeks . ( 2.1 ) 22.5 mg every 24 weeks . ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "trelstar ( triptorelin pamoate injectable suspension ) supplied single dose vial flip-off cap containing sterile lyophilized triptorelin pamoate microgranules incorporated biodegradable copolymer lactic glycolic acids , injection kit consisting vial adapter , 21 gauge 1 \u00bd \u201d injection needle , pre-filled syringe containing sterile water injection , usp , 2 ml . trelstar 3.75 mg \u2013 ndc 74676-5902-1 : 3.75 mg slightly yellow microgranules provided vial violet flip-off cap injection kit . trelstar 11.25 mg \u2013 ndc 74676-5904-1 : 11.25 mg slightly yellow microgranules provided vial yellow green flip-off cap injection kit . trelstar 22.5 mg \u2013 ndc 74676-5906-1 : 22.5 mg slightly yellow microgranules provided vial dark green flip-off cap injection kit . storage store 20-25\u00b0c ( 68-77\u00b0f ) . [ usp controlled room temperature . ] freeze trelstar .",
    "adverseReactions": "known hypersensitivity triptorelin component product , gnrh agonists gnrh . ( 4 )",
    "indications_original": "TRELSTAR is indicated for the treatment of advanced prostate cancer [see\u00a0\n                     \n                        Clinical Studies\u00a0(14)\n                     ].",
    "contraindications_original": "TRELSTAR is administered as a single intramuscular injection in either buttock. \u00a0Due to different release characteristics, the dosage strengths are not additive and must be selected based upon the desired dosing schedule. ( 2.1 ) 3.75 mg every 4 weeks. \u00a0( 2.1 ) 11.25 mg every 12 weeks. \u00a0( 2.1 ) 22.5 mg every 24 weeks. \u00a0( 2.1 )",
    "warningsAndPrecautions_original": "TRELSTAR (triptorelin pamoate for injectable suspension) is supplied as a single dose vial with a Flip-Off cap containing sterile lyophilized triptorelin pamoate microgranules incorporated in a biodegradable copolymer of lactic and glycolic acids, with injection kit consisting of a vial adapter, a 21 gauge 1 \u00bd\u201d injection needle, and a pre-filled syringe containing sterile water for injection, USP, 2\u00a0mL.\n                  \n                     TRELSTAR 3.75 mg \u2013 NDC 74676-5902-1: 3.75 mg of slightly yellow microgranules provided in a vial with a violet flip-off cap with injection kit.\n                  \n                     TRELSTAR 11.25 mg \u2013 NDC 74676-5904-1: 11.25 mg of slightly yellow microgranules provided in a vial with a yellow green flip-off cap with injection kit.\n                  \n                     TRELSTAR 22.5 mg \u2013 NDC 74676-5906-1: 22.5 mg of slightly yellow microgranules provided in a vial with a dark green flip-off cap with injection kit.\n                  \n                     \n                  \n                  \n                     Storage\n                  \n                  Store at 20-25\u00b0C (68-77\u00b0F).\u00a0\u00a0[See USP Controlled Room Temperature.]\u00a0 Do not freeze TRELSTAR.",
    "adverseReactions_original": "Known hypersensitivity to triptorelin or any other component of the product, or other GnRH agonists or GnRH.\u00a0 ( 4 )",
    "drug": [
        {
            "name": "Trelstar"
        }
    ]
}